Congratulations to our member Chris Jones, CEO of GlySure!
GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, today announced the close of its £7 million Series C financing round. GlySure will use this funding to complete clinical trials to support regulatory approval in the US and Europe.
Comments are closed